The knockdown of GPRC6A in PC3 cells was reported to significantly decrease tumor metastatic efficiency and invasiveness while increased expression of GPRC6A would enhance ERK and EMT signaling (Liu et al., 2016). This evidence concerns the gene GPRC6A and neoplasm.